United States · FDA National Drug Code directory

Depakote

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0074-7325_7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d
Product NDC
0074-7325
Form
TABLET, DELAYED RELEASE
Composition / generic term
Divalproex Sodium
Labeler
AbbVie Inc.
Marketing category
NDA
Marketing start / end (source format)
19830310
Source listing expiry
20271231

Source-listed ingredients

  • DIVALPROEX SODIUM — 125 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-7325-13) · 0074-7325-13

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →